Replies to post #122911 on Cytodyn Inc (CYDY)

[DonDonDonDon]

I have a theory that they are slow rolling enrollment on purpose. If the DSMB believes that the trial isn't going to fill for a long time, they might be more apt to support an EUA based on the interim. If an EUA isn't granted, I think Nader pays the penalty to unblind the data. Leronlimab will be promoted around the world based on the interim data. We are in a pandemic, people are going to want leronlimab even if the results are marginally good because it is so safe of a drug.